Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Deloitte
Teva
Fuji
Express Scripts
QuintilesIMS
Chinese Patent Office
Cantor Fitzgerald
Chubb

Generated: November 14, 2018

DrugPatentWatch Database Preview

Romiplostim - Biologic Drug Details

« Back to Dashboard

Summary for romiplostim
Tradenames:1
Patents:18
Applicants:1
BLAs:1
Suppliers: see list1
Pharmacology for romiplostim

US Patents for romiplostim

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up SIO2 MEDICAL PRODUCTS, INC. (Auburn, AL) ➤ Sign Up RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up University of the Sciences of Philadelphia (Philadelphia, PA) ➤ Sign Up RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up ➤ Sign Up RX search
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX company
Amgen NPLATE romiplostim INJECTABLE; SUBCUTANEOUS 125268 001 2008-08-22 ➤ Sign Up Amgen Inc. (Thousand Oaks, CA) ➤ Sign Up RX company
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for romiplostim

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
598 Luxembourg ➤ Sign Up PRODUCT NAME: ROMIPLOSTIM (NPLATE - ROMIPLOSTIM)
C0030 France ➤ Sign Up PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE IN FRANCE: EU/1/08/497/001 DU 20090204; REGISTRATION NO/DATE AT EEC: EU/1/08/497/001-002 DU 20090204
2009 00025 Denmark ➤ Sign Up
09/022 Ireland ➤ Sign Up PRODUCT NAME: ROMIPLOSTIM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
2009006,C1124961 Lithuania ➤ Sign Up PRODUCT NAME: ROMIPLOSTIMUM; REGISTRATION NO/DATE: EU/1/08/497/001-002 20090204
25/2009 Austria ➤ Sign Up PRODUCT NAME: ROMIPLOSTIM
0398 Netherlands ➤ Sign Up 300398, 20191022, EXPIRES: 20240203
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Chinese Patent Office
McKesson
UBS
Boehringer Ingelheim
Federal Trade Commission
Merck
Dow
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.